Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: Results from a phase I/II study

British Journal of Cancer

Volumn 94, Issue 7, 2006, Pages 976-981

  Klautke, G ^a   Kuchenmeister U ^a   Foitzik, T ^a   Ludwig, K ^b   Prall, F ^a   Klar, E ^a   Fietkau, R ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b Klinikum Sudstadt   (Germany)

Author keywords

Capecitabine; Irinotecan; Neoadjuvant chemoradiotherapy; Rectal cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CAPECITABINE; FLUOROURACIL; IRINOTECAN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAND FOOT SYNDROME; HUMAN; HYPERBILIRUBINEMIA; INFECTION; KIDNEY DISEASE; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; SUDDEN DEATH; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 33645728850     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603053     Document Type: Article

References (35)

1. Aschele C, Friso ML, Pucciarelli S, Lonardi S, Sartor L, Fabris G, Urso ED, Del Bianco P, Sotti G, Lise M, Monfardini S (2005) A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16: 1140-1146
2. Becerra CR, Cho L, Gregoreyk S, Simmang C, Frenkel EP, Verma UN (2005) A Phase I study with irinotecan, capecitabine and radiation therapy for patients with locally advanced or metastatic rectal cancer. Proc Am Soc Clin Oncol (Abstr 212)
3. Boothmann DA, Trask DK, Pardee AB (1987) Inhibition of potential lethal damage repair in human tumor cells by lapachone, an activator of topoisomerase I. Cancer Res 49: 605-612
4. Boscia RE, Korbut T, Holden SA, Ara G, Teicher BA (1993) Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum (II)-sensitive and - resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo. Int J Cancer 53: 118-123
5. Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G (1994) Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30: 169-175
6. Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM, Delclos ME, Lin EH, Janjan NA (2003) Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97: 517-524
7. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355: 1041-1047
8. Duck LR, Sempoux C, Honhon B, Coster B, Coche J-C, Kerger J, Canon J-L, Humblet Y, Scalliet P, Machiels J-P (2004) A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma. Proc Am Soc Clin Oncol (Abstr 3552)
9. Dunst J, Reese T, Sutter T, Zuhlke H, Hinke A, Kolling-Schlebusch K, Frings S (2002) Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 20: 1005-1009
10. Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36: 564-572
11. Gollins SW, Myint S, Levine E, Morris J, Haylock B, Susnerwala S, Saunders M, Biswas A (2005) Phase I study of radiotherapy (RT) plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer. Proc Am Soc Clin Oncol (Abstr 3565)
12. Hermanek P, Wittekind C (1994) The pathologist and the residual tumor (R) classification. Pathol Res Pract 190: 115-123
13. Hofheinz R, von Gerstenberg-Helldorf B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Muldner A, Hehlmann R, Post S, Hochhaus A, Willeke F (2005) Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J Clin Oncol 23: 1350-1357
14. Hurby G, Barton M, Miles S, Carroll S, Nasser E, Stevens G (2003) Site of local recurrence after surgery, with or without chemotherapy, for rectal cancer: Implication for radiotherapy field design. Int J Radiat Oncol Biol Phys 55: 138-143
15. Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24: 107-112
16. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J (1999) Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44: 1027-1038
17. Kaminsky-Forrett MC, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, Guillemin F, Bey P (1998) Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 42: 935-941
18. Kennedy AS, Kwok Y, Batko-Yovino S, Van Echo DA (2004) A phase I study of preoperative capecitabine, irinotecan concurrent with radiation therapy for resectable rectal cancer. Proc Am Soc Clin Oncol (Abstr 268)
19. Klautke G, Feyerherd P, Ludwig K, Prall F, Foitzik T, Fietkau R (2005) Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 92: 1190-1197
20. Küchenmeister U, Kirchner R, Mellert J, Klautke G, Mucke R, Hopt UT, Fietkau R (2000) Erste Ergebnisse der neoadjuvanten simultanen Radiochemotherapie bei fortgeschrittenen Rektumkarzinomen. Strahlenther Onkol 176: 560-566
21. Liu G, Franssen E, Fitch M, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15: 110-115
22. Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J, Rischin D (2005) Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer 92: 655-661
23. Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G (2003) Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55: 132-137
24. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J (1992) Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 10: 1218-1224
25. Mitchell EP, Anne P, Fry R, Ahmad N, Boman B, Edmunston T, Rakinic J, Goldstein S, Rose L, Palazzo J, Cagir B, Kovatich A, Hauck W, Fishel R, Bonanni R, Hoey D, Rose D, Curran W (2001) Combined mortality therapy of locally advanced or recurrent adenocarcinoma of the rectum: report of a phase I trail of chemotherapy with CPT-11, 5-FU and concomitant irradiation. Proc Am Soc Clin Oncol (Abstr 519)
26. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331: 502-507
27. Reerink O, Verschueren RCJ, Szabo BG, Hospers GA, Mulder NH (2003) A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur J Cancer 39: 192-195
28. Riepl M, Pietsch A, Klautke G, Fehr R, Fietkau R (2000) Endoscopic pretherapeutic clipping for gastrointestinal tumors. A method for exact definition of the target volume. Strahlenther Onkol 176: 517-523
29. Rodel C, Grabenbauer GG, Schick C, Papadopoulos T, Hohenberger W, Sauer R (2000) Präoperative simultane Radiochemotherapie mit 5-Fluorouracil bei lokal fortgeschrittenen T4-Rektumprimärtumoren. Strahlenther Onkol 176: 161-167
30. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackerland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914
31. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidtberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740
32. Sawada N, Ishikawa T, Sekiguchi F, Tanaka Y, Ishitsuka H (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 10: 2948-2953
33. Schüller J, Cassidy J, Dumont E, Roos B, Durston S, Banken L, Utoh M, Mori K, Weidekamm E, Reigner B (2000) Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 45: 291-297
34. Van Cutsem E, Hoff PM, Harper P, Bukowski RM, Cunningham D, Dufour P, Graeven U, Lokich J, Madajewicz S, Maroun JA, Marshall JL, Mitchell EP, Perez-Manga G, Rougier P, Schmiegel W, Schoelmerich J, Sobrero A, Schilsky RL (2004) Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomized, phase III trials. Br J Cancer 90: 1190-1197
35. Videtic G, Fisher B, Perera FE, Bauman GS, Kocha WI, Taylor M, Vincent MD, Plewes EA, Engel CJ, Stitt LW (1998) Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Rad Oncol Biol Phys 42: 319-324